Home/Filings/4/0001209191-23-024264
4//SEC Filing

Leavitt Chase C. 4

Accession 0001209191-23-024264

CIK 0001260990other

Filed

Apr 13, 8:00 PM ET

Accepted

Apr 14, 6:00 AM ET

Size

6.2 KB

Accession

0001209191-23-024264

Insider Transaction Report

Form 4
Period: 2023-04-12
Leavitt Chase C.
General Counsel/Secretary
Transactions
  • Purchase

    Common Stock

    2023-04-12$0.29/sh+15,000$4,35096,901 total
  • Purchase

    Common Stock

    2023-04-13$0.29/sh+10,000$2,900106,901 total

Issuer

Oncternal Therapeutics, Inc.

CIK 0001260990

Entity typeother

Related Parties

1
  • filerCIK 0001777467

Filing Metadata

Form type
4
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 6:00 AM ET
Size
6.2 KB